Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency (Q33820696)

29 July 2017

1 reference

title

Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency (English)

1 reference

linear IgA bullous dermatosis

29 July 2017

1 reference

1 reference

1 reference

1 reference

Klein PA

1

1 reference

29 July 2017

Callen JP

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

Journal of the American Academy of Dermatology

29 July 2017

published in

1 reference

29 July 2017

volume

42

1 reference

29 July 2017

issue

2 Pt 2

1 reference

29 July 2017

page(s)

316-323

1 reference

Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Linear IgA disease in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Histology of linear IgA disease, dermatitis herpetiformis, and bullous pemphigoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Vancomycin-induced linear IgA bullous dermatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

A bullous eruption in an elderly woman. Vancomycin-associated linear IgA dermatosis (LAD)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Vancomycin-induced linear IgA bullous dermatosis (LABD).

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Linear IgA dermatosis related to vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Adult linear IgA disease associated with an erythema multiforme-like drug reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Captopril-triggered linear IgA bullous dermatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Phenytoin-induced linear IgA bullous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Drug-induced linear IgA disease: target antigens are heterogeneous

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Vancomycin-associated linear IgA dermatosis. A report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Drug-induced linear IgA bullous dermatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Bullous drug eruption treated with amputation. A challenging case of vancomycin-induced linear IgA disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Vancomycin-associated linear IgA bullous dermatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Linear IgA bullous dermatosis associated with vancomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Clinical, demographic, and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin. Report of 2 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Amiodarone-induced linear IgA disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Linear IgA bullous dermatosis after heart transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120-kDa keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

The 97 kDa linear IgA bullous disease antigen is identical to a portion of the extracellular domain of the 180 kDa bullous pemphigoid antigen, BPAg2

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Identification of the target antigen in chronic bullous disease of childhood and linear IgA disease of adults

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Bullous pemphigoid-like lesions induced by phenacetin. Report of a case and an immunopathologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Linear IgA disease of adults: association with lymphoproliferative malignancy and possible role of other triggering factors

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Acute linear IgA dermatosis in a child following varicella

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

Linear IgA deposition associated with cutaneous varicella-zoster infection: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2800%2990102-6

7 January 2021

10.1016/S0190-9622(00)90102-6

Identifiers

DOI

1 reference

29 July 2017

1 reference